This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
After Sun Pharma appealed an injunction handed down in New Jersey federal court ...
Ask a healthcare professional to name a psychiatric medicine and chances are the...
A FDA generic drug office was eliminated — and the implications will be felt not...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
Alzheon’s attempt to rescue a once-failed idea for treating Alzheimer’s disease ...
Human medicines European public assessment report (EPAR): Relvar Ellipta, flutic...
Alzheon’s attempt to rescue a once-failed idea for treating Alzheimer’s disease ...
A group of academics is arguing that countries seeking access to a groundbreakin...
Alzheon’s attempt to rescue a once-failed idea for treating Alzheimer’s disease ...
Human medicines European public assessment report (EPAR): Kayfanda, odevixibat, ...
Human medicines European public assessment report (EPAR): Ebglyss, Lebrikizumab,...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...
Human medicines European public assessment report (EPAR): Kaftrio, ivacaftor,tez...
Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Da...
Keros Therapeutics is considering whether it needs to find a buyer, while streng...
The company settled with several purchaser plaintiffs in an antitrust case that ...
Human medicines European public assessment report (EPAR): Kaletra, lopinavir,rit...
Opthea’s staff are paying for its clinical failures. Days after back-to-back flo...
Minutes - PDCO minutes of the 25-28 February 2025 meeting
HMPC meeting report on European Union herbal monographs, guidelines and other ac...